BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28795410)

  • 21. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
    Sang W; Wang CF; Cheng YF; Liu X; Li XX; Gulinar A; Li JZ; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells.
    Wu SJ; Sadigh S; Lane AA; Pinkus GS
    Am J Clin Pathol; 2023 May; 159(5):455-463. PubMed ID: 36880313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality.
    Sumarriva Lezama L; Chisholm KM; Carneal E; Nagy A; Cascio MJ; Yan J; Chang CC; Cherry A; George TI; Ohgami RS
    Histopathology; 2018 Nov; 73(5):767-776. PubMed ID: 29884995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous presentation preceding acute myeloid leukemia with CD4+/CD56+ expression misdiagnosed as a blastic plasmocytoid dendritic cell neoplasm: A case report.
    Szablewski V; Costes V; Bret C; Dereure O; Yosr H; Alame M; Cacheux V
    J Cutan Pathol; 2018 Aug; 45(8):610-614. PubMed ID: 29660158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotypic CD56 Variation Within a Single Patient With Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Lopez AT; Shaw KS; Yamany T; Husain S; Geskin L
    JAMA Dermatol; 2018 Apr; 154(4):492-494. PubMed ID: 29490374
    [No Abstract]   [Full Text] [Related]  

  • 26. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Sukswai N; Aung PP; Yin CC; Li S; Wang W; Wang SA; Ortega V; Lyapichev K; Nagarajan P; Alfattal R; Angelova E; Tang Z; Loghavi S; Kanagal-Shamanna R; Miranda RN; Pemmaraju N; Bhalla K; Konopleva M; Medeiros LJ; Khoury JD
    Am J Surg Pathol; 2019 Oct; 43(10):1429-1437. PubMed ID: 31261288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
    Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blastic plasmacytoid dendritic cell neoplasm: A clinicopathological diagnostic dilemma report of three cases with review of literature.
    Purkait S; Gupta S; Bakhshi S; Mallick S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S471-S474. PubMed ID: 36511007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
    Zhang X; Sun J; Yang M; Wang L; Jin J
    Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Wang W; Xu J; Khoury JD; Pemmaraju N; Fang H; Miranda RN; Yin CC; Hussein SE; Jia F; Tang Z; Hu S; Konopleva M; Medeiros LJ; Wang SA
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.
    Reichard KK; Burks EJ; Foucar MK; Wilson CS; Viswanatha DS; Hozier JC; Larson RS
    Am J Surg Pathol; 2005 Oct; 29(10):1274-83. PubMed ID: 16160468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
    Lim MS; Lemmert K; Enjeti A
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.
    Cota C; Vale E; Viana I; Requena L; Ferrara G; Anemona L; Metze D; Fink-Puches R; Wiesner T; Cerroni L
    Am J Surg Pathol; 2010 Jan; 34(1):75-87. PubMed ID: 19956058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
    Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
    Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study of 7 cases].
    Xiong J; Chen H; Zhang M; Zheng Y; Qiao J; Sheng N; Xu X; Sun J
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(8):599-602. PubMed ID: 24762690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.
    Julia F; Petrella T; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dereure O; Wetterwald M; d'Incan M; Grange F; Cornillon J; Tertian G; Maubec E; Saiag P; Barete S; Templier I; Aubin F; Dalle S
    Br J Dermatol; 2013 Sep; 169(3):579-86. PubMed ID: 23646868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia.
    Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H
    Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Khoury JD
    Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
    Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
    Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.